A Randomized, Placebo-Controlled Trial of the Discontinuation of Long-Term Antipsychotics in Dementia
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The objectives of this randomized clinical trial were to investigate the impact of the discontinuation of long-term antipsychotics in residents with dementia in chronic care institutions and to identify clinical predictors of safe discontinuation. Subjects included 34 residents with dementia who were on antipsychotics for more than 6 months and whose behavior was currently stable. Subjects were randomized to either continue receiving their regular dosage of antipsychotics or to receive placebo for 6 months. Early withdrawal from the study was not statistically different between the groups (relative risk [RR] = 1.57, 95% confidence interval [CI] 0.76-3.26), and though not significantly different, subjects in the placebo group were more likely to be withdrawn from the study because of worsening behavior (RR = 1.25, 95% Cl 0.33-4.76). Three subjects in the placebo group were withdrawn from the study due to worsening of extrapyramidal symptoms. The active treatment group had more behavioral problems (e.g., physical aggression towards others, p < .05) compared to the placebo group. The placebo group developed more apathy, but balancing this outcome was a relative improvement in cognitive functioning. Baseline antipsychotic dose was predictive of behavioral worsening upon discontinuation of long-term antipsychotic drugs. The primary limitation of the study was the small sample size. In conclusion, a trial of discontinuation of antipsychotics should be considered in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia
Schneider, L. S., Pollock, V. E., & Lyness, S. A. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb02407.x · Cited by 650 · cited 1×
“Even for acute behavioral management, though, the evidence suggests that typical antipsychotics (neuroleptics) exhibit limited efficacy, with response rates of approximately 60% versus nearly 40% for placebo (Schneider et al., 1990).”
Background
Cited by
Antipsychotic Drug Use and Mortality in Older Adults with Dementia
Gill, S. S., Bronskill, S. E., Normand, S.-L. T., Anderson, G. M., Sykora, K., Lam, K., Bell, C. M., Lee, P. E., Fischer, H. D., Herrmann, N., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-11-200706050-00006 · Cited by 624
Self-citationMaher, A. R., Maglione, M., Bagley, S., Suttorp, M., Hu, J.-H., Ewing, B., Wang, Z., Timmer, M., Sultzer, D., & Shekelle, P. G. (2011) · JAMA · doi:10.1001/jama.2011.1360 · Cited by 558
Page, A. T., Clifford, R. M., Potter, K., Schwartz, D., & Etherton‐Beer, C. D. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12975 · Cited by 496
Medication Withdrawal Trials in People Aged 65 Years and Older: A Systematic Review
Iyer, S., Naganathan, V., McLachlan, A. J., & Le Couteur, D. G. (2008) · Drugs & Aging · doi:10.2165/0002512-200825120-00004 · Cited by 339
Kua, C.-H., Mak, V. S. L., & Huey Lee, S. W. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.10.026 · Cited by 271
Metadata
- Authors
- van Reekum, R., Conn, D., Clarke, D., Cohen, T., Ostrander, L., Herrmann, N., & Eryavec, G.
- Venue
- International Psychogeriatrics
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 14
- Issue
- 2
- Pages
- 197-210
- ISSN
- 1041-6102 (ISSN-L)
- OpenAlex
- W2004158056
- Cited by
- 74
- References
- 1
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Randomized, Placebo-Controlled Trial of the Discontinuation of Long-Term Antipsychotics in Dementia. https://app.cochat.ai/papers/10.1017/s1041610202008396
- The paper
- van Reekum, R., Conn, D., Clarke, D., Cohen, T., Ostrander, L., Herrmann, N., & Eryavec, G. (2002). A Randomized, Placebo-Controlled Trial of the Discontinuation of Long-Term Antipsychotics in Dementia. International Psychogeriatrics. https://doi.org/10.1017/s1041610202008396
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.